Future Capital
Europe, Hessen, Germany, Frankfurt
Description
Future Capital invests in companies engaged in the life sciences and chemistry, including nanotechnology and material sciences.
Investor Profile
Future Capital has made 17 investments, with 0 in the past 12 months and 12% as lead.
Stage Focus
- Series A (29%)
- Series B (18%)
- Series D (12%)
- Angel (12%)
- Series C (6%)
- Private Equity (6%)
- Seed (6%)
- Series Unknown (6%)
- Series E (6%)
Country Focus
- China (65%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- Germany (29%)
- United States (6%)
Industry Focus
- Biotechnology
- Software
- Biopharma
- Pharmaceutical
- Artificial Intelligence (Ai)
- Health Care
- Information Technology
- Enterprise
- Machine Learning
- Automotive
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
